#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Mucopolysaccharidosis III Glioma Adenovirus infection Henoch-Schonlein purpura Oesophageal squamous cell carcinoma stage III Ventricular tachycardia Thymic carcinoma Osteomyelitis Atypical haemolytic uraemic syndrome Fatty acid oxidation disorder Infective uveitis Adenoid cystic carcinoma Myotonia Keratosis follicular Penile squamous cell carcinoma More trials…

    Learn about Rare Diseases

    Congenital hypotransferrinaemia – Basic Information Hereditary neuropathic amyloidosis – Basic Information Waldenstrom’s macroglobulinaemia recurrent – Life with Disease Primary mediastinal large B-cell lymphoma Adrenogenital syndrome – Life with Disease Uterine leiomyosarcoma – Diagnostics Focal segmental glomerulosclerosis Burkitt’s lymphoma – Diagnostics Angiosarcoma metastatic – Life with Disease Primary immunodeficiency syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ociperlimab Regn5668 Amoxicillin Sodium Ceftazidime Rocatinlimab Radotinib Dihydrochloride BW-20805 Sertraline Hydrochloride Estradiol Hemihydrate Taletrectinib Gen1046 Diltiazem Hydrochloride Azd5004 Dinoprostone LY3537021 Mebeverine Hydrochloride Acetylsalicylic Acid Ph. Eur. Oxycodone Hydrochloride Cart 19/22 T Cells Alendronate Sodium Monohydrate More therapies…

    Learn about Your Condition

    Osteosarcoma recurrent Breast angiosarcoma metastatic Chronic hepatic failure Rhabdomyosarcoma Spermatocele Nephroblastoma Childhood asthma Hyperadrenocorticism Hepatobiliary cancer Spinal cord injury Cushing's syndrome Alport's syndrome Porphyria non-acute Leukoencephalopathy Appendicitis perforated More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Cardiac failure

  • A study of finerenone with standard treatment for children and young adults from birth to 18 years with heart failure and left ventricular systolic dysfunction

    Recruiting

    3 1 1
    Investigated Diseases:
    • Left ventricular dysfunction
    • Cardiac failure
    Investigated Drugs:
    • Finerenone
    Austria Belgium Bulgaria Czechia Finland Germany +7

  • A study testing the reduction of heart failure drug combination in patients with heart failure in remission

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiac failure
    Investigated Drugs:
    • Bisoprolol Fumarate
    • Empagliflozin
    • Lisinopril
    Belgium

  • Study of PF-07328948 tablets compared to placebo in adults with heart failure to evaluate effects on symptoms and physical function

    Recruiting

    2 1
    Investigated Diseases:
    • Cardiac failure
    Bulgaria Czechia France Hungary Poland Spain

  • Evaluating the Effect of Vicadrostat and Empagliflozin Combination Compared to Empagliflozin Alone in Patients with Heart Failure and Reduced Left Ventricular Function

    Recruiting

    3 1 1
    Investigated Drugs:
    • Bi 690517
    • Empagliflozin
    Belgium Bulgaria Czechia Denmark Germany Hungary +6

  • Study on Heart Failure Patients Using Hyperpolarized [1-13C]pyruvate to Explore Heart Metabolism

    Recruiting

    1 1 1
    Investigated Diseases:
    • Cardiac failure
    Investigated Drugs:
    • Pyruvic Acid
    Denmark

  • Study on the Effects of CDR132L on Heart Structure and Function in Patients with Heart Failure and Left Ventricular Hypertrophy

    Recruiting

    2 1
    Investigated Diseases:
    • Cardiac failure
    Germany Poland Spain
1 2 3 … 8
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!